Back to funds
View filing
Boxer Capital Management, LLC
hedge fundUpdated 27 days agoManaged by Boxer Capital Management, Llc • Latest filing Q2 2026
Portfolio value
$1.3B
Q2 2026
Filings
7
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 7 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2024 | $1.2B |
| Q1 2025 | $332.5M |
| Q2 2025 | $198.7M |
| Q3 2025 | $313.7M |
| Q4 2025 | $456.9M |
| Q1 2026 | $761.7M |
| Q2 2026 | $1.3B |
Top holdings
63 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | T TNGX TANGO THERAPEUTICS INC | $340M | 10.88M | 25.61% | — |
| 2 | R RVMDW REVOLUTION MEDICINES INC | $93.6M | 500.0K | 7.05% | — |
| 3 | A AAVXF ABIVAX SA | $80.6M | 605.0K | 6.07% | — |
| 4 | Q QURE UNIQURE NV | $69.2M | 1.50M | 5.21% | — |
| 5 | K KOD KODIAK SCIENCES INC | $57.6M | 1.48M | 4.34% | — |
| 6 | K KYMR KYMERA THERAPEUTICS INC | $49.2M | 429.1K | 3.71% | — |
| 7 | D DFTX DEFINIUM THERAPEUTICS INC | $47M | 998.5K | 3.54% | — |
| 8 | Q QCOM REPLIMUNE GROUP INC | $44.1M | 3.98M | 3.32% | — |
| 9 | C CELC CELCUITY INC | $43.6M | 416.5K | 3.28% | — |
| 10 | Q QTTB Q32 BIO INC | $40.1M | 3.15M | 3.02% | — |
| 11 | C CAPR CAPRICOR THERAPEUTICS INC | $33.6M | 1.40M | 2.53% | — |
| 12 | ? N/A PRECIGEN INC | $29.4M | 5.15M | 2.21% | — |
| 13 | C CORT CORCEPT THERAPEUTICS INC | $29.2M | 335.5K | 2.20% | — |
| 14 | ? N/A Surrozen Inc. | $27M | 1.11M | 2.03% | — |
| 15 | P PB PROTAGONIST THERAPEUTICS INC | $20.8M | 170.0K | 1.57% | — |
| 16 | V VIR VIR BIOTECHNOLOGY INC | $19M | 1.87M | 1.43% | — |
| 17 | P PCVX VAXCYTE INC | $18.9M | 325.0K | 1.42% | — |
| 18 | U URGN UROGEN PHARMA LTD | $18.4M | 500.0K | 1.39% | — |
| 19 | C CRVS CORVUS PHARMACEUTICALS INC | $16.4M | 1.10M | 1.24% | — |
| 20 | ? N/A PTC THERAPEUTICS INC | $16.3M | 200.0K | 1.23% | — |